| KREBSBIO | | | 104.14 8.79 7.78% |
CEO
Jitendra Shah is CEO MD of Krebs Biochemicals and
| Age | 56 |
| Address | Kothapalli Village, Visakhapatnam, India, 531031 |
| Phone | 91 91 2114 4984 |
| Web | https://krebsbiochem.com |
Krebs Biochemicals Management Efficiency
The company has return on total asset
(ROA) of
(0.0532) % which means that it has lost $0.0532 on every $100 spent on assets. This is way below average. Krebs Biochemicals' management efficiency ratios could be used to measure how well Krebs Biochemicals manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Krebs Biochemicals'
Intangible Assets are increasing as compared to previous years.
Krebs Biochemicals and has accumulated 2.39
B in total debt. Debt can assist Krebs Biochemicals until it has trouble settling it off, either with new capital or with free cash flow. So, Krebs Biochemicals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Krebs Biochemicals and sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Krebs to invest in growth at high rates of return. When we think about Krebs Biochemicals' use of debt, we should always consider it together with cash and equity.
Similar Executives
Krebs Biochemicals and (KREBSBIO) is traded on National Stock Exchange of India in India and employs 191 people. Krebs Biochemicals is listed under Pharmaceuticals category by Fama And French industry classification.
Management Performance
Krebs Biochemicals and Leadership Team
Elected by the shareholders, the Krebs Biochemicals' board of directors comprises two types of representatives: Krebs Biochemicals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Krebs. The board's role is to monitor Krebs Biochemicals' management team and ensure that shareholders' interests are well served. Krebs Biochemicals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Krebs Biochemicals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Krebs Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Krebs Biochemicals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Krebs Stock
Krebs Biochemicals financial ratios help investors to determine whether Krebs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Krebs with respect to the benefits of owning Krebs Biochemicals security.